About Huang Yen-Chen
Form D filings for Bilayer Therapeutics in 2023 list Huang Yen-Chen as director.
Huang Yen-Chen first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Huang Yen-Chen in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Huang Yen-Chen works with at each company, as listed on that company's latest Form D.
Bilayer Therapeutics, Inc. · Form D, Aug 4, 2023
JK
Joshua Korzenik
Director
TC
Thomas Collet
President and director
RL
Robert Langer
Director
DZ
David Zhu
Director
CT
Carlo Traverso
Director